Enzo Biochem (ENZ) Reports Q2 Loss of $0.02
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Total operating expenses: 27.54M
Today's EPS Names:
EPAC, SAR, KRUS, More
Financial Fact:
Total operating expenses: 27.54M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Enzo Biochem (NYSE: ENZ) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $7.3 million.
For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DigitalOcean projects record Q2 2026 results with RPO above $800M
- Odeon Capital Starts Office Properties Income Trust (OPI) at Buy
- Raytheon partners with Diehl Defence to double Stinger output
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
